Back
Eaton Vance Tax-Managed Buy-Write Income Fund Vs. AnaptysBio, Inc. Industry Stock Comparison
Buy
66
ETB
Eaton Vance Tax-Managed Buy-Write Income Fund
Last Price:
$14.56
Seasonality Move:
2.64%
Sell
47
ANAB
AnaptysBio, Inc.
Last Price:
$57.92
Seasonality Move:
5.3%
Buy
66
Eaton Vance Tax-Managed Buy-Write Income Fund (ETB)
is a Buy
Is Eaton Vance Tax-Managed Buy-Write Income Fund a Buy, Sell or Hold?
-
The current Eaton Vance Tax-Managed Buy-Write Income Fund [ETB] share price is $14.61. The Score for ETB is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
ETB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
AnaptysBio, Inc. (ANAB)
is a Sell
Is AnaptysBio, Inc. a Buy, Sell or Hold?
-
The current AnaptysBio, Inc. [ANAB] share price is $57.68. The Score for ANAB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
ANAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ETB Stock Price Chart
What is Eaton Vance Tax-Managed Buy-Write Income Fund's stock price today?
-
The Eaton Vance Tax-Managed Buy-Write Income Fund share price today is $14.61Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ETB is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANAB Stock Price Chart
What is AnaptysBio, Inc.'s stock price today?
-
The AnaptysBio, Inc. share price today is $57.68The current trend is relatively stagnant and ANAB is experiencing slight selling pressure.
ETB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 46.15 | Sell |
| Chaikin Money Flow: | 26462 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.41 - 15.23) | Sell |
| Bollinger Bands (100): | (14.83 - 15.49) | Sell |
ANAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 46.79 | Sell |
| Chaikin Money Flow: | -120538 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.32 - 64.78) | Sell |
| Bollinger Bands (100): | (41.49 - 58.03) | Buy |
ETB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.41 | Buy |
| 20-day SMA: | 14.69 | Sell |
| 50-day SMA: | 15.12 | Sell |
| 200-day SMA: | 14.97 | Sell |
| 8-day EMA: | 14.48 | Buy |
| 20-day EMA: | 14.67 | Sell |
| 50-day EMA: | 14.95 | Sell |
| 200-day EMA: | 14.91 | Sell |
ANAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.51 | Sell |
| 20-day SMA: | 61.65 | Sell |
| 50-day SMA: | 55.97 | Buy |
| 200-day SMA: | 37.84 | Buy |
| 8-day EMA: | 58.76 | Sell |
| 20-day EMA: | 59.68 | Sell |
| 50-day EMA: | 56.33 | Buy |
| 200-day EMA: | 41.98 | Buy |
Eaton Vance Tax-Managed Buy-Write Income Fund Earnings Growth & ETB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
AnaptysBio, Inc. Earnings Growth & ANAB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.65 per share, a decrease next quarter of $0.13 per share, a decrease this year of $2.63 per share, and an increase next year of $0.54 per share.
Eaton Vance Tax-Managed Buy-Write Income Fund Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AnaptysBio, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||